Smh Capital Advisors Inc Merck & Co., Inc. Transaction History

Smh Capital Advisors Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $195,339 - $227,613	1,725 New	1,725 $227,000
Q2 2023 Aug 07, 2023	SELL	$108.61 - $118.38 $2,932 - $3,196	-27 Reduced 1.29%	2,061 $237,000
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $46,323 - $51,687	-450 Reduced 17.73%	2,088 $222,000
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $5,246 - $6,726	60 Added 2.42%	2,538 $281,000
Q3 2022 Nov 02, 2022	SELL	$84.53 - $94.96 $5,578 - $6,267	-66 Reduced 2.59%	2,478 $213,000
Q2 2022 Aug 10, 2022	SELL	$83.49 - $94.64 $5.02 Million - $5.69 Million	-60,167 Reduced 95.94%	2,544 $232,000
Q2 2022 Jul 27, 2022	BUY	$83.49 - $94.64 $5.24 Million - $5.93 Million	62,711 New	62,711 $1.03 Million

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Smh Capital Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Smh Capital Advisors Inc with notifications on news.